The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rifinah 300 / 150 mg Film Coated Tablets



Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/068/002

Main Information

Trade NameRifinah 300 / 150 mg Film Coated Tablets
Active SubstancesRifampicin
Isoniazid
Dosage FormFilm-coated tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/068/002

Group Information

ATC CodeJ04AM Combinations of drugs for treatment of tuberculosis
J04AM02 rifampicin and isoniazid

Status

License statusAuthorised
Licence Issued01/04/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back